Cardiac tissue engineering

Tissue Engineering Using Ceramics and Polymers

Volumn , Issue , 2007, Pages 335-356

  Chen, Q Z ^a   Harding, S E ^b   Ali, N N ^b   Jawad, H ^a   Boccaccini, A R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENGINEERING; INDUSTRIAL ENGINEERING;

CARDIAC TISSUE ENGINEERING;

TISSUE ENGINEERING;

EID: 51749102100     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845693817.2.335     Document Type: Chapter

References (64)

1. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., Durand D.J., Fitton T., Kuang J.Q., Stewart G., Lehrke S., Baumgartner W.W., Martin B.J., Heldman A.W., Hare J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005, 102(32):11474-11479.
2. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355(12):1222-1232.
3. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428(6983):668-673.
4. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114(6):763-776.
5. Carrier R.L., Rupnick M., Langer R., Schoen F.J., Freed L.E., Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tiss Eng 2002, 8(2):175-188.
6. Caspi O., Gepstein L. Stem cells for myocardial repair. Eur Heart J Suppl 2006, 8(Supplement E):E43-E54.
7. Chen M.K., Beierle E.A. Animal models for intestinal tissue engineering. Biomaterials 2004, 25(9):1675-1681.
8. Cima L.G., Vacanti J.P., Vacanti C., Ingber D., Mooney D., Langer R. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng - Trans ASME 1991, 113(2):143-151.
9. El Fray M., Boccaccini A.R. Novel hybrid PET/DFA-TiO2 nanocomposites by in situ polycondensation. Mater Lett 2005, 59(18):2300-2304.
10. Eschenhagen T. Engineering myocardial tissue. Circ Res 2005, 97(12):1220-1231.
11. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., Zimmerman W., Dohmen H.H., Schafer H., Bishopric N., Wakatsuki T., Elson E.L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb J 1997, 11(8):683-694.
12. Etzion S., Battler A., Barbash I.M., Cagnano E., Zarin P., Granot Y., Kedes L.H., Kloner R.A., Leor J. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cellul Cardio 2001, 33(7):1321-1330.
13. Etzion S., Kedes L.H., Kloner R.A., Leor J. Myocardial regeneration: present and future trends. Am J Cardiovasc Drugs 2001, 1(4):233-244.
14. Fidkowski C., Kaazempur-Mofrad M.R., Borenstein J., Vacanti J.P., Langer R., Wang Y.D. Endothelialized microvasculature based on a biodegradable elastomer. Tiss Eng 2005, 11(1-2):302-309.
15. Freed L.E., VunjakNovakovic G. Microgravity tissue engineering. In Vitro Cell Develop Biol - Animal 1997, 33(5):381-385.
16. Gerecht-Nir S., Radisic M., Park H., Cannizzaro C., Boublik J., Langer R., Vunjak-Novakovic G. Biophysical regulation during cardiac development and application to tissue engineering. Int J Develop Biol 2006, 50(2-3):233-243.
17. Harding S.E., Gorelik J., Ali N.N., Brito-Martins M. The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacol Therapeut 2007, 113:341-353.
18. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001, 108(3):407-414.
19. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004, 22(10):1282-1289.
20. Kessler P.D., Byrne B.J. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 1999, 61:219-242.
21. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996, 98(1):216-224.
22. Kofidis T., Lenz A., Boublik J., Akhyari P., Wachsmann B., Stahl K.M., Haverich A., Leyh R.G. Bioartificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept. Eur J Cardio-Thorac Surg 2003, 24(6):906-911.
23. Kofidis T., de Bruin J.L., Hoyt G., Ho Y., Tanaka M., Yamane T., Lebl D.R., Swijnenburg R.J., Chang C.P., Quertermous T., Robbins R.C. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 2005, 24(6):737-744.
24. Koh G.Y., Klug M.G., Soonpaa M.H., Field L.J. Differentiation and long-term survival of C2c12 myoblast grafts in heart. J Clin Invest 1993, 92(3):1548-1554.
25. Laflamme M.A., Gold J., Xu C.H., Hassanipour M., Rosler E., Police S., Muskheli V., Murry C.E. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005, 167(3):663-671.
26. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y.H., Woodard S., Lin L.Z., Cai C.L., Lu M.M., Reth M., Platoshyn O., Yuan J.X.J., Evans S., Chien K.R. Postnatal isl1+cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433(7026):647-653.
27. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003, 5(6):485-489.
28. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., Granot Y., Cohen S. Bioengineered cardiac grafts - a new approach to repair the infarcted myocardium?. Circulation 2000, 102(19):56-61.
29. Leor J., Amsalem Y., Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Therapeut 2005, 105(2):151-163.
30. Li R.K., Mickle D.A.G., Weisel R.D., Zhang J., Mohabeer M.K. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996, 78(2):283-288.
31. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A.G., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100(19):63-69.
32. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grogaard H.K., Bjornerheim R., Brekke M., Muller C., Hopp E., Ragnarsson A., Brinchmann J.E., Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355(12):1199-1209.
33. Menard C., Hagege A.A., Agbulut O., Barro M., Morichetti M.C., Brasselet C., Bel A., Messas E., Bissery A., Bruneval P., Desnos M., Puceat M., Menasche P. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 2005, 366(9490):1005-1012.
34. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., Salio M., Battaglia M., Latronico M.V.G., Coletta M., Vivarelli E., Frati L., Cossu G., Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95(9):911-921.
35. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes - role of coculture with visceral endoderm-like cells. Circulation 2003, 107(21):2733-2740.
36. Murry C.E., Whitney M.L., Laflamme M.A., Reinecke H., Field L.J. Cellular therapies for myocardial infarct repair. Cold Spring Harb Symp Quant Biol 2002, 67:519-526.
37. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B.S., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428(6983):664-668.
38. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., Entman M.L., Schneider M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003, 100(21):12313-12318.
39. Orlic D., Kajstura J., Chimenti S., Bodine D.M., Leri A., Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Hematopoietic Stem Cells 2000 Basic and Clinical Sciences 2001, 221-230. New York Acad. Sci, New York. 938.
40. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L., Kuhl U., Schultheiss H.P. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99(21):2750-2756.
41. Pfister O., Mouquet F., Jain M., Summer R., Helmes M., Fine A., Colucci W.S., Liao R. CD31(-) but not CD31(+) cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005, 97(1):52-61.
42. Pittenger M.F., Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004, 95(1):9-20.
43. Radisic M., Vunjak-Novakovic G. Cardiac tissue engineering. J Serbian Chem Soc 2005, 70(3):541-556.
44. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts - a study in normal and injured rat hearts. Circulation 1999, 100(2):193-202.
45. Satin J., Kehat L., Caspi O., Huber I., Arbel G., Itzhaki I., Magyar J., Schroder E.A., Perlman I., Gepstein L. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol - London 2004, 559(2):479-496.
46. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J.T., Corti R., Mathey D.G., Hamm C.W., Suselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355(12):1210-1221.
47. Scorsin M., Hagege A.A., Marotte F., Mirochnik N., Copin H., Barnoux M., Sabri A., Samuel J.L., Rappaport L., Menasche P. Does transplantation of cardiomyocytes improve function of infarcted myocardium?. Circulation 1997, 96(9):188-193.
48. Scorsin M., Hagege A., Vilquin J.T., Fiszman M., Marotte F., Samuel J.L., Rappaport L., Schwartz K., Menasche P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg 2000, 119(6):1169-1175.
49. Shachar M., Cohen S. Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Failure Rev 2003, 8(3):271-276.
50. Shin M., Ishii O., Sueda T., Vacanti J.P. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004, 25(17):3717-3723.
51. Snir M., Kehat I., Gepstein A., Coleman R., Itskovitz-Eldor J., Livne E., Gepstein L. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol - Heart Circul Physiol 2003, 285(6):H2355-H2363.
52. Soonpaa M.H., Koh G.Y., Klug M.G., Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994, 264(5155):98-101.
53. Sundback C.A., Shyu J.Y., Wang Y.D., Faquin W.C., Langer R.S., Vacanti J.P., Hadlock T.A. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials 2005, 26(27):5454-5464.
54. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutchinson K.A., Glower D.D., Kraus W.E. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998, 4(8):929-933.
55. Temenoff J.S., Lu L., Mikos A.G. Bone tissue engineering using synthetic biodegradable polymer scaffolds. Bone Tissue Engineering 2000, 455-462. EM Squared, Toronto. J.E. Davies (Ed.).
56. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147.
57. Vunjak-Novakovic G., Radisic M., Obradovic B. Cardiac tissue engineering: effects of bioreactor flow environment on tissue constructs. J Chem Tech Biotech 2006, 81(4):485-490.
58. Wang Y.D., Ameer G.A., Sheppard B.J., Langer R. A tough biodegradable elastomer. Nat Biotechnol 2002, 20(6):602-606.
59. Xu C.H., Police S., Rao N., Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002, 91(6):501-508.
60. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., Tomaselli G.F., Li R.A. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes - insights into the development of cell-based pacemakers. Circulation 2005, 111(1):11-20.
61. Zammaretti P., Jaconi M. Cardiac tissue engineering: regeneration of the wounded heart. Curr Opin Biotechnol 2004, 15(5):430-434.
62. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000, 68(1):106-114.
63. Zimmermann W.H., Didie M., Doker S., Melnychenko I., Naito H., Rogge C., Tiburcy M., Eschenhagen T. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 2006, 71(3):419-429.
64. Zmora S., Glicklis R., Cohen S. Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication. Biomaterials 2002, 23(20):4087-4094.